[
1. Bilezikian JP. Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2018;103(11):3993-4004.10.1210/jc.2018-01225
]Search in Google Scholar
[
2. Macfarlane DP, Yu N, Leese GP. Subclinical and asymptomatic parathyroid disease: implications of emerging data. Lancet Diab Endocrinol. 2013;1(4):329-340.10.1016/S2213-8587(13)70083-4
]Search in Google Scholar
[
3. Borissova A-M, Vlahov JD, Krivoshiev SG et al. The prevalence of hyperparathyroidism in the Bulgarian population – Analysis of an epidemiological study by the Bulgarian Society of Endocrinology (BSE) – 2012. J Endocrinologia. 2019;24(4):202-212.
]Search in Google Scholar
[
4. Pawlowska M, Cusano NE. An overview of normocalcemic primary hyperparathyroidism. Curr Opin Endocrinol Diab Obes. 2015;22(6):413-421.10.1097/MED.000000000000019826512768
]Search in Google Scholar
[
5. Kim JK, Chai YJ, Chung JK et al. The prevalence of primary hyperparathyroidism in Korea: a population-based analysis from patient medical records. Ann Surg Treat Res. 2018;94(5):235-239.10.4174/astr.2018.94.5.235593193329732354
]Search in Google Scholar
[
6. Collier A, Portelli M, Ghosh S et al. Primary hyperparathyroidism: Increasing prevalence, social deprivation, and surgery. Endocr Res. 2017;42(1):31-35.10.3109/07435800.2016.1169545
]Search in Google Scholar
[
7. Clark BL. Asymptomatic Primary Hyperparathyroidism. In: Brandi ML, ed. Parathyroid Disorders. Focusing on Unmet Needs. Frontiers of Hormone Research 51, Basel, Karger, 2019:13-22.10.1159/000491035
]Search in Google Scholar
[
8. Souberbielle JC, Cavalier E, Cormier C. How to manage an isolated elevated PTH? Ann Endocrinol (Paris). 2015;76(2):134-141.10.1016/j.ando.2015.03.005
]Search in Google Scholar
[
9. Lips P, Netelenbos JC, Doorn Lv et al. Stimulation and suppression of intact parathyroid hormone (PTH1–84) in normal subjects and hyperparathyroid patients. Clin Endocrinol. 1991;35(1):35-40.10.1111/j.1365-2265.1991.tb03493.x
]Search in Google Scholar
[
10. Zhu X, Shan C, Zhu Q et al. Clinical value of calcium load test in differential diagnosis of different types of hyperparathyroidism. Int J Clin Exp Med. 2014;7(12):5445-5452. eCollection 2014.
]Search in Google Scholar
[
11. Malberti F, Farina M, Imbasciati E. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism. Nephrol Dial Transpl. 1999;14(10):2398-2406.10.1093/ndt/14.10.239810528664
]Search in Google Scholar
[
12. Keller EX, De Coninck V, Pietropaolo A et al. Metabolic evaluation: Place of the calcium load test: How, when, for whom, and why? Eur Urol Focus. 2021;7(1):26-30.10.1016/j.euf.2020.12.01933419710
]Search in Google Scholar
[
13. Borissova AM, Shinkov A, Vlahov J et al. Prevalence of vitamin D deficiency, insufficiency and sufficiency in Bulgarian population aged 20-80 years. Endocrinologia. 2012;17(3):122-134.
]Search in Google Scholar
[
14. Reiss E, Canterbury JM. Application of radioimmunoassay to differentiation of adenoma and hyperplasia and to preoperative localization of hyperfunctioning parathyroid glands. N Engl J Med. 1969;280(25):1381-1385.10.1056/NEJM1969061928025045771363
]Search in Google Scholar
[
15. Murray TM, Peacock M, Powell D et al. Non-autonomy of hormone secretion in primary hyperparathyroidism. Clin Endocrinol (Oxf). 1972;1(3):235-246.10.1111/j.1365-2265.1972.tb00394.x4198020
]Search in Google Scholar
[
16. Birnbaumer ME, Schneider AB, Palmer D et al. Secretion of parathyroid hormone by abnormal human parathyroid glands in vitro. J Clin Endocrinol Metab. 1977;45(1):105-113.10.1210/jcem-45-1-105874057
]Search in Google Scholar
[
17. Broadus AE, Deftos LJ, Bartter FC. Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test. J Clin Endocrinol Metab. 1978;46(3):477-487.10.1210/jcem-46-3-477221521
]Search in Google Scholar
[
18. Sørensen HA, Schwarz P, McNair P et al. Calcium clamp technique: suppression of serum intact PTH by induced hypercalcaemia in normal man and primary hyperparathyroidism. Scand J Clin Lab Invest. 1992;52(6):457-465.10.3109/003655192090901221411258
]Search in Google Scholar
[
19. Titon I, Cailleux-Bounacer A, Basuyau JP et al. Evaluation of a standardized short-time calcium suppression test in healthy subjects: interest for the diagnosis of primary hyperparathyroidism. Eur J Endocrinol. 2007;157(3):351-357.10.1530/EJE-07-013217766719
]Search in Google Scholar
[
20. Hagag P, Revet-Zak I, Hod N et al. Diagnosis of normocalcemic hyperparathyroidism by oral calcium loading test. J Endocrinol Invest. 2003;26(4):327-332.10.1007/BF0334518012841540
]Search in Google Scholar
[
21. Zhao L, Zhang MJ, Zhao HY et al. PTH inhibition rate is useful in the detecti on of early-stage primary hyperparathyroidism. Clin Biochem. 2011;44(10-11):844-848.10.1016/j.clinbiochem.2011.03.14221524645
]Search in Google Scholar
[
22. Rao SD, Bhadada SK, Parfitt MA. Parathyroid growth normal and abnormal. In: Bilezikian JP, ed. The Parathyroids: basic and clinical concepts. New York, Academic Press (Elsevier), 2015:258-278.
]Search in Google Scholar
[
23. Sklavenitis-Pistofidis R, Papaioannou O, Kotsa K. Primary hyperparathyroidism and the road to surgery: appraisal of the proceedings of the four international workshops (1990, 2002, 2008, 2014) on primary hyperparathyroidism. Hormones (Athens). 2015;14(2):201-210.10.14310/horm.2002.158126158652
]Search in Google Scholar